ACE inhibition is renoprotective among obese patients with proteinuria.
about
Autophagy: A Novel Therapeutic Target for Diabetic NephropathyObesity and Kidney Disease: Hidden Consequences of the Epidemic.Evaluating hormonal mechanisms of vitamin D receptor agonist therapy in diabetic kidney disease: the VALIDATE-D studyChronic kidney disease among overweight and obesity with and without metabolic syndrome in an urban Chinese cohort.Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study.Body mass index in 1.2 million adolescents and risk for end-stage renal disease.Obesity, Renin-Angiotensin System Blockade and Risk of Adverse Renal Outcomes: A Population-Based Cohort StudyNovel drugs and intervention strategies for the treatment of chronic kidney disease.Obesity in CKD--what should nephrologists know?Consequences of morbid obesity on the kidney. Where are we going?Obesity, hypertension, and chronic kidney disease.Influence of dietary protein on glomerular filtration before and after bariatric surgery: a cohort study.Differential diagnosis of glomerular disease: a systematic and inclusive approach.Body mass index and body fat distribution as renal risk factors: a focus on the role of renal haemodynamics.The regenerative potential of parietal epithelial cells in adult mice.Obesity and risk of death or dialysis in younger and older patients on specialized pre-dialysis care.Increased body mass index is a risk factor for end-stage renal disease in the Chinese Singapore population.Hypertension in pediatric patients with chronic kidney disease: management challenges.Obesity-mediated autophagy insufficiency exacerbates proteinuria-induced tubulointerstitial lesions.Visceral adiposity and renal function: an observational study from SPECT-China.Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson Heart Study.Effect of Bariatric Surgery on CKD Risk.Anti-Inflammatory Effects and Prediction of Blood Pressure Response by Baseline Inflammatory State in Catheter-Based Renal Denervation.Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment.Obesity and kidney disease: Hidden consequences of the epidemic.Obesity and kidney disease: hidden consequences of the epidemic.Early Treatment With Enalapril and Later Renal Injury in Programmed Obese Adult Rats.Obesity and kidney disease: hidden consequences of the epidemic.Obesity and kidney disease: hidden consequences of the epidemic.Obesity modulates the association between systolic blood pressure and albuminuria.Obesity and kidney disease: hidden consequences of the epidemic
P2860
Q26771919-C405192D-DE68-48C3-B26C-07EAB274BADBQ30235506-C050FA7D-8BBD-4E29-8A9A-74F9CDA7A8B8Q34967905-84BEAA1F-98BE-485B-9FDF-E37ABB11F974Q35666503-F413E430-B1A2-43BD-B89E-09A9A51C8D37Q36069813-AE64CE5D-6C5E-4132-8FAE-CD1C4E51D861Q37085746-8B9208B6-EE52-4A5B-A741-4D2E8D76CDDEQ37114337-4945D4E0-03A5-4F4B-A129-494329C4BE66Q37219043-5AC76F0E-0296-48B2-8816-94906B68B1E9Q37260238-E8BA1B71-A3B5-460B-B541-C8380808425EQ37511029-56E6DC64-EF60-47BE-A4EA-16D6658ADB7CQ37601245-5329D85E-C8E8-4AA0-897F-E4455BE4B640Q37671788-6680FBED-62C4-4341-B4C4-E70A723DE8A7Q38139836-5B286A3B-03AB-4E5F-9AF4-42FBD80947E5Q38157805-1CAB80D9-B7C2-4D66-8B83-027A5F2D397CQ38545021-3450F64F-909E-4210-A826-F35DB816CEC6Q40057240-09B68EA4-E242-46A3-960A-C88E34F5A258Q40192525-FC10B03C-83B7-4175-A946-0C92C871B619Q41200646-5E3C43CB-9BCA-4022-8C36-530BBD0FF5F6Q42932026-67ABF27D-4C98-4685-94BB-4A5F71DD3C21Q43976102-62C9B618-31C0-4329-91B7-8FE14BECB92FQ46941041-84851680-3047-4077-BE7A-5ED90958EA07Q47563194-074C567D-E58B-4900-BBD9-05F63E6E086DQ48249017-964415B1-9D4F-4D5E-97B2-182C390DABADQ48698019-29935C4B-BF70-4031-B7A2-9569EFA5EA29Q52720558-057FFBD4-310C-449C-8540-60E11764BB66Q52906732-15E0C383-5FE1-4657-A23E-189A85315431Q52978291-37A9DC2E-E30A-4149-95C4-1A67D0061CCAQ53081563-9F187C8B-9E09-4E57-BD48-890EFE239CF5Q53347632-75EDD585-E44D-41ED-BBF9-A9C567320EBBQ54314102-E83093A4-7CE3-4171-8B3A-3CFA604B39E4Q57771331-0C8FE6B2-BB3F-482A-9271-8595D6A085C7
P2860
ACE inhibition is renoprotective among obese patients with proteinuria.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
ACE inhibition is renoprotective among obese patients with proteinuria.
@ast
ACE inhibition is renoprotective among obese patients with proteinuria.
@en
type
label
ACE inhibition is renoprotective among obese patients with proteinuria.
@ast
ACE inhibition is renoprotective among obese patients with proteinuria.
@en
prefLabel
ACE inhibition is renoprotective among obese patients with proteinuria.
@ast
ACE inhibition is renoprotective among obese patients with proteinuria.
@en
P2093
P2860
P50
P356
P1476
ACE inhibition is renoprotective among obese patients with proteinuria.
@en
P2093
Daniela Leonardis
Francesca Mallamaci
Giovanni Tripepi
REIN Study Group
Rocco Tripepi
P2860
P304
P356
10.1681/ASN.2010090969
P577
2011-04-28T00:00:00Z